Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or Fludrocortisone | Synapse
March 3, 2026
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or Fludrocortisone
CK
Christy Khouderchah
University of Washington
MK
Mehdi Karami
AP
Andrew J. Portuguese
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Ver todo
Puntos clave
Idiopathic hypotension occurs in CAR-T therapy patients, leading to significant management challenges.
Key findings indicate that midodrine and fludrocortisone provide symptomatic relief in this population.
Assessment of treatment effects on blood pressure was performed through observational analysis.
Management of hypotension post-CAR-T remains critical; additional validation in larger cohorts is needed.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Khouderchah et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76090c6e9836116a2d6d3
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.930